Reevaluating Acute Treatment Strategies for Spontaneous Spinal Cord Infarction: Insights from a Propensity Score-Matched Study
Highlight
• Standard antiplatelet therapy demonstrated a significantly lower all-cause mortality compared to thrombolytic treatment in spontaneous SCI.
• No significant difference was found between the two approaches in hospital readmission or rehabilitation utilization at 180 days.
• Findings suggest potential risks from off-label thrombolytic use in SCI and underscore the need for high-quality, prospective studies.
• Propensity score matching adjusted for 68 clinical covariates, enhancing the validity of comparative outcome assessment.
Study Background
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.